Ya‐Qiu Long

1.1k total citations
51 papers, 838 citations indexed

About

Ya‐Qiu Long is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Ya‐Qiu Long has authored 51 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 16 papers in Organic Chemistry and 9 papers in Infectious Diseases. Recurrent topics in Ya‐Qiu Long's work include Chemical Synthesis and Analysis (14 papers), HIV/AIDS drug development and treatment (9 papers) and Receptor Mechanisms and Signaling (6 papers). Ya‐Qiu Long is often cited by papers focused on Chemical Synthesis and Analysis (14 papers), HIV/AIDS drug development and treatment (9 papers) and Receptor Mechanisms and Signaling (6 papers). Ya‐Qiu Long collaborates with scholars based in China, United States and United Kingdom. Ya‐Qiu Long's co-authors include Jianping Lin, Fenghua Zhang, Yanli Song, Cheng Yang, Tongyu Zhu, Qiang Yu, Ruiming Rong, Xing Fan, Jianhua Liu and Dian Peng and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Ya‐Qiu Long

51 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ya‐Qiu Long China	18	391	380	99	50	49	51	838
Chris Dockendorff United States	17	951 2.4×	458 1.2×	45 0.5×	65 1.3×	51 1.0×	50	1.5k
Qianbin Li China	18	295 0.8×	467 1.2×	157 1.6×	47 0.9×	65 1.3×	66	886
Kazuyuki Miyashita Japan	20	391 1.0×	570 1.5×	91 0.9×	49 1.0×	10 0.2×	65	1.2k
Giovanni Marzaro Italy	21	609 1.6×	578 1.5×	175 1.8×	38 0.8×	9 0.2×	80	1.4k
Hiroyuki Kakinuma Japan	14	288 0.7×	325 0.9×	65 0.7×	25 0.5×	14 0.3×	43	744
Gary B. Phillips United States	22	533 1.4×	542 1.4×	66 0.7×	49 1.0×	21 0.4×	42	1.2k
Peter D. Gorycki United States	13	146 0.4×	344 0.9×	166 1.7×	93 1.9×	20 0.4×	29	735
Ying K. Yee United States	16	291 0.7×	275 0.7×	58 0.6×	81 1.6×	39 0.8×	24	885
Geeta Patel United Kingdom	18	224 0.6×	288 0.8×	166 1.7×	24 0.5×	28 0.6×	45	732
Kevin N. Dack United Kingdom	12	221 0.6×	260 0.7×	99 1.0×	35 0.7×	34 0.7×	22	683

Countries citing papers authored by Ya‐Qiu Long

Since Specialization

Citations

This map shows the geographic impact of Ya‐Qiu Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Qiu Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Qiu Long more than expected).

Fields of papers citing papers by Ya‐Qiu Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Qiu Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Qiu Long. The network helps show where Ya‐Qiu Long may publish in the future.

Co-authorship network of co-authors of Ya‐Qiu Long

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Qiu Long. A scholar is included among the top collaborators of Ya‐Qiu Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Qiu Long. Ya‐Qiu Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yicheng, Ling Li, Jiayuan Kong, et al.. (2025). Long-acting injectable nanoparticle formulation for sustained release of anti-TNF-α antibody therapeutic in ulcerative colitis treatment. Journal of Controlled Release. 380. 1005–1016. 1 indexed citations

Long, Ya‐Qiu, et al.. (2025). Sequential flash nanocomplexation and flash nanoprecipitation enables scalable assembly of doxorubicin-loaded nanoparticles. Nanomedicine Nanotechnology Biology and Medicine. 68. 102843–102843. 2 indexed citations

Huang, Bin, et al.. (2024). Concise Asymmetric Total Syntheses of (+)-Dihydropleurotinic Acid and (−)-Pleurotin, Enabling Rapid Late-Stage Diversification. SHILAP Revista de lepidopterología. 4(11). 4206–4211. 2 indexed citations

Chen, Cheng, Shimeng Guo, He Li, et al.. (2023). Discovery of orally effective and safe GPR40 agonists by incorporating a chiral, rigid and polar sulfoxide into β-position to the carboxylic acid. European Journal of Medicinal Chemistry. 251. 115267–115267. 5 indexed citations

Rashad, Adel A., Zhilong Wang, E. Gary, et al.. (2018). Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus–Cell Interface. Journal of Medicinal Chemistry. 61(11). 5020–5033. 7 indexed citations

Peng, Dian, Bin Cao, Yingjun Zhou, & Ya‐Qiu Long. (2018). The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential. European Journal of Medicinal Chemistry. 149. 148–169. 21 indexed citations

Wang, Zhilong, et al.. (2018). Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrido[4,3-c]azepin-5-one-based novel chemotype CCR2 antagonists via scaffold hopping strategy. Bioorganic & Medicinal Chemistry. 26(12). 3559–3572. 9 indexed citations

Chen, Cheng, et al.. (2016). GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space. Bioorganic & Medicinal Chemistry Letters. 26(23). 5603–5612. 28 indexed citations

Cheng, Yu, et al.. (2016). Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency. Bioorganic & Medicinal Chemistry Letters. 26(12). 2900–2906. 12 indexed citations

10.

Yang, Cheng, Yuanyuan Wu, Wu Ju, et al.. (2015). Caspase-3 siRNA and CHBP Ameliorate Renal Ischemia Reperfusion Injury in Mice. Hong Kong Journal of Nephrology. 17(2). S92–S92. 1 indexed citations

11.

Yang, Cheng, Ye Cao, Yi Zhang, et al.. (2015). Cyclic helix B peptide inhibits ischemia reperfusion-induced renal fibrosis via the PI3K/Akt/FoxO3a pathway. Journal of Translational Medicine. 13(1). 355–355. 34 indexed citations

12.

Lin, Jianping, et al.. (2014). 2-Aryl-3-carbonylquinolones：Design, Synthesis and Biological Evaluation of Novel HCV NS5B Polymerase Inhibitors. Acta Chimica Sinica. 72(8). 906–906. 9 indexed citations

13.

Yang, Cheng, Zhongliang Xu, Zitong Zhao, et al.. (2014). A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(11). 2306–2317. 45 indexed citations

14.

Sun, Xiaoxiao, Midan Ai, Ying Wang, et al.. (2013). Selective Induction of Tumor Cell Apoptosis by a Novel P450-mediated Reactive Oxygen Species (ROS) Inducer Methyl 3-(4-Nitrophenyl) Propiolate. Journal of Biological Chemistry. 288(13). 8826–8837. 51 indexed citations

15.

Wang, Yong, Zhongliang Xu, Jing Ai, et al.. (2012). Investigation on the 1,6-naphthyridine motif: discovery and SAR study of 1H-imidazo[4,5-h][1,6]naphthyridin-2(3H)-one-based c-Met kinase inhibitors. Organic & Biomolecular Chemistry. 11(9). 1545–1562. 16 indexed citations

16.

Song, Yanli, et al.. (2007). Forward- and reverse-synthesis of piperazinopiperidine amide analogs: a general access to structurally diverse 4-piperazinopiperidine-based CCR5 antagonists. Organic & Biomolecular Chemistry. 5(16). 2690–2690. 14 indexed citations

17.

Song, Yanli, Jinzhi Tan, Xiaomin Luo, & Ya‐Qiu Long. (2006). Utilization of 3′-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2–SH2 domain. Organic & Biomolecular Chemistry. 4(4). 659–659. 4 indexed citations

18.

Song, Yanli, Peter P. Roller, & Ya‐Qiu Long. (2004). Development of l-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity. Bioorganic & Medicinal Chemistry Letters. 14(12). 3205–3208. 10 indexed citations

19.

Song, Yanli, et al.. (2004). Facile synthesis of 4-substituted-4-aminopiperidine derivatives, the key building block of piperazine-based CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(14). 3675–3678. 13 indexed citations

20.

Long, Ya‐Qiu, et al.. (2001). Functional preference of the constituent amino acid residues in a phage‐library‐based nonphosphorylated inhibitor of the Grb2‐SH2 domain. Journal of Peptide Research. 57(6). 447–454. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact